Tokyo-based Sosei Group Corp has made further progress with its orexin program, which is being developed in conjunction with its spin-off companies Orexia Ltd and Inexia Ltd.
Read MoreThe Minnesota-based CPAP manufacturer is supporting local and regional medical communities with an emergency supply of EUA BiPAP devices purchased by the state of Minnesota and South Dakota medical facilities.
Read MoreVanda Pharmaceuticals Inc has completed a Type A Meeting with the US Food and Drug Administration (FDA) on May 8, 2020, it has reached agreement with the FDA to resubmit its application for HETLIOZ (tasimelteon) for the treatment of Smith-Magenis Syndrome.
Read More
The study findings also may provide clues to why some people sleep more than others and why some sleep disorders arise.
Read MoreIt is hoped study findings will increase our understanding of how sleep can influence brain health and long-term dementia risk.
Read More